United States Molecular Diagnostics Market Overview

Base Year: 2024

Historical Years: 2019-2024

Forecast Years: 2025-2033

Market Size in 2024: USD 4.8 Billion

​Market Forecast in 2033: USD 7.4 Billion

Market Growth Rate (2025-33): 4.9%

The United States molecular diagnostics market size reached USD 4.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The increasing prevalence of chronic diseases, adoption of personalized medication, rapid advancements in technology, favorable government policies, sudden shift towards eco-friendly processes, and the growing collaborations represent some of the key factors driving the market.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/united-states-molecular-diagnostics-market/requestsample

United States Molecular Diagnostics Market Trends and Drivers:

Presence of Technology in the US Molecular Diagnostic Market has contributed significantly towards rapid growth in the Molecular diagnostics market in the United States. New technologies such as next-generation sequencing (GSN) and CRISPR-based assays are making an impact on disease detection, actually speeding up the times and more accurate detection measures. Rising numbers of chronic and infectious diseases are pushing healthcare providers to have an early intervention by using molecular diagnostics tools. The increased adoption of personalized treatment plans is becoming a vivid reason for such tests, as they offer general insights into risk factors and drug responses. With increasing investment in biotechnology R&D, these markets will continue their upward path supported by both private and public funding initiates.

Another would be the growing expansion of the point-of-care testing (POCT), which would allow molecular diagnostic results from outside conventional laboratory settings. Portable devices and rapid PCR techniques allow clinics and even home users to perform quite complex analyses after minimal training. Increasing numbers of the older U.S. population are contributing to the market growth as older adults, about 50% of whom, continuously need monitoring for cancers, cardiovascular diseases, and other neurological disorders. Moreover, commercializing has become very much easier as new assays and companion diagnostics have gained regulatory approvals, thereby encouraging many more players to come into business. AI and machine learning into the diagnostic platforms contribute to better data interpretation thus minimizing errors and increasing workflow efficiency, which in effect makes the provision more attractive to health care providers.

Increased awareness and preventive trends in healthcare are among the forces driving market growth. Consumers are being more proactive in genetic testing and early detection of diseases, hence the push for direct-to-consumer (DTC) diagnostic molecular kits. Co-operations between diagnostic companies and pharmaceutical companies are breeding innovation in oncology and diagnostics of rare diseases. Telemedicine has also opened more doors for testing as virtual consultations increasingly recommend at-home molecular testing. Insurance provisions that are improving for these advanced diagnostics have made cost to be no more an issue, thus assuring continued growth in the market in the years to come.

United States Molecular Diagnostics Market Industry Segmentation:

Product Insights:

• Reagents and Kits
• Instruments
• Software and Services

Technology Insights:

• Polymerase Chain Reactions (PCR)
• Hybridization
• DNA Sequencing
• Microarray
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Others

Application Insights:

• Infectious Diseases Diagnostics
• Oncology
• Genetic Testing
• Blood Screening
• Others

End User Insights:

• Hospitals
• Laboratories
• Others

Regional Insights:

• Northeast
• Midwest
• South
• West

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Ask Our Expert & Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=11071&flag=C

Key highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-2033)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: [email protected] 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145